New treatment for MS

In the news today, Merck has been working on a new treatment for MS -- cladribine. It seems to increase the amount of time between relapses. The current question is whether it is safe for chronic use.

WTOP news article clicky

Post a comment in response:

From:

Anonymous This account has disabled anonymous posting.

OpenID

Dreamwidth account

If you don't have an account you can create one now.

Subject

HTML doesn't work in the subject.

Formatting type

Message